Clinical Trials Directory

Trials / Completed

CompletedNCT01528657

Ventricular Pace Suppression Versus Intrinsic Rhythm Support Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
230 (actual)
Sponsor
Biotronik SE & Co. KG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to intra-individually compare the performances of two pacemaker algorithms designed to reduce unnecessary right ventricular pacing: Intrinsic Rhythm Support Plus (IRSplus) and Ventricular Pace Suppression (VpS). The study will compare ventricular pacing percentage, long-term atrio-ventricular conduction time, occurrences of atrial tachyarrhythmic events and atrial fibrillation burden percentage in patients implanted with a pacemaker for Sick Sinus Syndrome.

Conditions

Interventions

TypeNameDescription
OTHERVentricular Pace Suppression (Vps)Unnecessary ventricular pacing is avoided by promoting intrinsic conduction. In case of intrinsic conduction, the device switches from a DDD mode to an ADI mode.
OTHERIntrinsic rhythm support (IRSplus)All parameters of the AV hysteresis functions are set in a way to maintain spontaneous AV conduction of the patient's heart as long as possible.

Timeline

Start date
2011-12-01
Primary completion
2015-08-01
Completion
2015-08-01
First posted
2012-02-08
Last updated
2015-10-22

Locations

20 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT01528657. Inclusion in this directory is not an endorsement.

Ventricular Pace Suppression Versus Intrinsic Rhythm Support Study (NCT01528657) · Clinical Trials Directory